220
103.9k
Chapter:

110+ Pharmacokinetics Solved MCQs

in Biopharmaceutics and Pharmacokinetics

These multiple-choice questions (MCQs) are designed to enhance your knowledge and understanding in the following areas: Bachelor of Pharmacy (B. Pharma) .

Chapters

Chapter: Pharmacokinetics
1.

The concentration of drug in plasma above which toxic effects are precipitated is known as

A. Maximum safe concentration
B. Minimum Effective Concentration
C. Intensity of Action
D. Duration of Action
Answer» A. Maximum safe concentration
2.

When rate is independent of the reactant concentration, then it is called

A. zero order reaction
B. Pseudo zero order reaction
C. First order reaction
D. Second order reaction
Answer» A. zero order reaction
3.

Which of the following is the half life of zero order reaction?

A. t1/2 = A0 /2k
B. t1/2 = 0.693/2k
C. t1/2 = A0 /2
D. t1/2 = 2k/ A0
Answer» A. t1/2 = A0 /2k
4.

The unit of k for zero order reaction is

A. moles/litre/second
B. moles
C. moles/second
D. moles/litre
Answer» A. moles/litre/second
5.

Which of the following is the half life of first order reaction?

A. t1/2 = A0 / 2k
B. t1/2 = 0.693 / 2k
C. tl/2 = 2k
D. tl/2 = 0.693 / k
Answer» D. tl/2 = 0.693 / k
6.

Which of the following is not a pharmacokinetic parameters that describe the plasma level time curve?

A. tmax
B. cmax
C. Area under Curve
D. Minimum Effective Concentration
Answer» D. Minimum Effective Concentration
7.

The drug concentration between Minimum Effective Concentration and Maximum Safe Concentration is called

A. Therapeutic range
B. Area under curve
C. Peak response
D. Pharmacological response
Answer» A. Therapeutic range
8.

tmax indicates

A. drug absorption rate
B. drug elimination rate
C. drug distribution rate
D. drug metabolism rate
Answer» A. drug absorption rate
9.

What Will be the approximate Tmax of a drug exhibiting Ka of 2 hr-1 and K of 0.2 hr-1 ?

A. 1.2 hr
B. 2.4 hr
C. 4.8 hr
D. 2.0 hr
Answer» A. 1.2 hr
10.

A drug solution has half life of 21 days. Assuming that drug undergoes first order kinetics, how long will it take for the potency to drop to 90% of initial potency?

A. 3.2 days
B. 9.6 days
C. 16 days
D. 6.2 days
Answer» A. 3.2 days
11.

A suspension shows zero-order kinetic with a rate constant 2mg/ml.month. The dose of suspension is 20mg/ml. The biological half life of the above dosage form is

A. 5 months
B. 1 month
C. 3 months
D. 2 months
Answer» A. 5 months
12.

Drug showing zero order kinetic of elimination

A. Are more common than those showing first order kinetic
B. Show plot of drug concentration vs time (linear Plot)
C. Decrease in concentration exponentially with time
D. Have half life independent of dose
Answer» B. Show plot of drug concentration vs time (linear Plot)
13.

Elimination after 4 half lives in first order kinetics is

A. 84%
B. 93%
C. 80%
D. 4%
Answer» B. 93%
14.

Which one is irrational statement for first order kinetics?

A. Half life is a function of concentration of reactants
B. Reaction rate is not a function of concentration of reactants
C. Both a & b
D. All of these
Answer» D. All of these
15.

T % (Half life time) of a drug can determine all of the following except

A. Closing interval
B. Therapeutic dose
C. Elimination time
D. Steady plasma concentration
Answer» B. Therapeutic dose
16.

The area under serum concentration time curve of drug represents

A. The biological half life of the drug
B. Amount of drug biotransformed
C. The amount of drug absorbed
D. The amount of drug excreted in urine
Answer» D. The amount of drug excreted in urine
17.

Under non compartment analysis the following formula is used for calculation

A. MRT = AUMC / AUC
B. AUMC = MRT / AUC
C. MRT = AUC / AUMC
D. AUC = AUMC / MRT
Answer» A. MRT = AUMC / AUC
18.

Under compartment modeling, Wegner-Nelson-Method involves

A. Determination of absorption rate constant (Ka) from %ARA Vs time curve
B. Determination of elimination rate constant (Ka) from % ARA Vs time curve
C. Determination of absorption rate constant (Ke) from %ARA •Vs Concentration curve
D. Determination of plasma half life
Answer» A. Determination of absorption rate constant (Ka) from %ARA Vs time curve
19.

The steady-state concentration of a drug can be double by:

A. Doubling the both rate of infusion and concentration of drug.
B. Doubling the rate of infusion only.
C. Doubling the loading dose but maintaining the infusion rate.
D. Tripling the rate of infusion.
Answer» B. Doubling the rate of infusion only.
20.

In compartment modeling the term "Open" indicates

A. Unidirectional input and output
B. All compartments are open
C. Body is open
D. None of the above
Answer» A. Unidirectional input and output
21.

Select the formula to calculate steady state concentration follows IV infusion

A. Css= Infusion Rate/ Clearance
B. Css= Clearance / Infusion Rate
C. Css= Infusion Rate X Clearance
D. Css = Infusion Rate - Clearance
Answer» A. Css= Infusion Rate/ Clearance
22.

IV infusion model follows

A. Zero order absorption and first order elimination kinetic
B. No absorption and first order elimination kinetic
C. No absorption and Zero order elimination kinetic
D. First order absorption and first order elimination kinetic
Answer» A. Zero order absorption and first order elimination kinetic
23.

Select the formula to calculate elimination half life

A. t1/2 = 0.693 + Ke
B. t1/2 = 0.693 / Ke
C. t1/2 = 0.693 × Ke
D. t1/2 = 0.693 – Ke
Answer» B. t1/2 = 0.693 / Ke
24.

The constants that represent reversible transfer of drug between compartments are called as

A. microconstants
B. macroconstant
C. Infusion
D. Lag time
Answer» A. microconstants
25.

In two compartment model, extravascular route of drug administration, there are ……phases

A. absorption phase,
B. Distribution phase
C. elimination phase,
D. All of the above
Answer» D. All of the above
26.

Ka is estimated by

A. Method of Residuals
B. Loo Riegelman method
C. Both a and b
D. None of the above
Answer» C. Both a and b
27.

The central compartment consist of

A. Highly perfused tissues
B. Slowly equilibrate tissues
C. Both a and b
D. Reproductive org
Answer» A. Highly perfused tissues
28.

What does "pharmacokinetics" includes?

A. Mechanisms of drug action
B. Localization of drug action
C. Interaction of substances
D. Excretion of substances
Answer» D. Excretion of substances
29.

Pharmacokinetics is:

A. The study of absorption, distribution, metabolism and excretion of drugs
B. The study of biological and therapeutic effects of drugs
C. The study of methods of new drug development
D. The study of mechanisms of drug action
Answer» A. The study of absorption, distribution, metabolism and excretion of drugs
30.

What does "pharmacokinetics" includes?

A. Drug biotransformation in the organism
B. Influence of drugs on metabolism processes
C. Influence of drugs on genes
D. Complications of drug therapy
Answer» A. Drug biotransformation in the organism
31.

Parenteral administration:

A. Is too slow for emergency use
B. Cannot be used with unconsciousness patients
C. Generally results in a less accurate dosage than oral administration
D. Usually produces a more rapid response than oral administration
Answer» D. Usually produces a more rapid response than oral administration
32.

The volume of distribution (Vd) relates:

A. The amount of a drug in the body to the concentration of a drug in plasma
B. An uncharged drug reaching the systemic circulation
C. Single to a daily dose of an administrated drug
D. An administrated dose to a body weight
Answer» A. The amount of a drug in the body to the concentration of a drug in plasma
33.

For the calculation of the volume of distribution (Vd) one must take into account:

A. Concentration of substance in urine
B. Therapeutical width of drug action
C. A daily dose of drug
D. Concentration of a substance in plasma
Answer» D. Concentration of a substance in plasma
34.

……….. is a mathematical concept which describes a space in the body which a drug appears to occupy.

A. Order of reaction
B. Compartment
C. Distribution
D. Elimination
Answer» B. Compartment
35.

………………..is the manner in which a drug is taken.

A. Dosage regimen
B. Dosage volume
C. Dosage loading
D. None of the above
Answer» A. Dosage regimen
36.

…………………it is the extent to which a drug will accumulate relative to the first dose can be quantified by an accumulation factor R.

A. Accumulation Index
B. Apparent volume of drug distribution
C. Accumulation factor
D. None of the above
Answer» A. Accumulation Index
37.

………………… is an initial higher dose of a drug that may be given at the beginning of a course of treatment before dropping down to a lower maintenance dose.

A. Primary Dose
B. Initial Dose
C. Loading dose
D. None of the above
Answer» C. Loading dose
38.

The compartment models provide visual representation of various rate processes involved in drug disposition. Given statement is:

A. False
B. True
C. Cannot say
D. None of the above
Answer» B. True
39.

...................is composed of highly perfused tissues, extracellular fluid, and blood with rapid and uniform drug distribution.

A. Central compartment
B. Peripheral compartment
C. both of the above
D. None of the above
Answer» A. Central compartment
40.

……………composed of groups of tissues with lower blood perfusion and different affinity the drug with slow drug distribution.

A. Central compartment
B. Peripheral compartment
C. Both of the above
D. None of the above
Answer» B. Peripheral compartment
41.

A multicompartment model assumes that all transfer rate processes for the passage of drug into or out of individual compartments are…………….. processes.

A. First-order
B. Second order
C. Pseudo order
D. None of the above
Answer» A. First-order
42.

The multicompartment models are intended to provide…………….

A. Therapeutic activity of the drug
B. Achieve maximum efficacy
C. Both of the above
D. None of the above
Answer» C. Both of the above
43.

The biological half-life of drug:

A. is a constant physical property of the drug
B. is a constant chemical property of the drug
C. may be increased in patients with impaired renal failure
D. may be decreased in patients by giving the drug by rapid I.V. injection
Answer» C. may be increased in patients with impaired renal failure
44.

The half life of a drug eliminated by first order elimination kinetics will be longer in individuals who have an:

A. increased volume of distribution or increased clearance
B. increased volume of distribution or decreased clearance
C. decreased volume of distribution or increased clearance
D. decreased volume of distribution or decreased clearance
Answer» B. increased volume of distribution or decreased clearance
45.

Half life (t1/2) is the time required to:

A. change the amount of a drug in plasma by half during elimination
B. metabolize a half of an introduced drug into the active metabolite
C. absorb a half of an introduced drug
D. bind a half of an introduced drug to plasma proteins
Answer» A. change the amount of a drug in plasma by half during elimination
46.

Half life (t1/2) does not depend on:

A. biotransformation
B. time of drug absorption
C. concentration of a drug in plasma
D. rate of drug elimination
Answer» B. time of drug absorption
47.

Elimination rate constant (Kelim) is defined by the following parameter:

A. rate of absorption
B. maximal concentration of a substance in plasma
C. highest single dose
D. half life (t1/2)
Answer» D. half life (t1/2)
48.

Systemic clearance (Cl) is related with:

A. only the concentration of substances in plasma
B. only the elimination rate constant
C. volume of distribution, half life and elimination rate constant
D. bioavailability and half life
Answer» C. volume of distribution, half life and elimination rate constant
49.

Biological Half life equation for first order process is

A. t1/2 = a/2K
B. t1/2 = 0.693/K
C. ) t1/2 = 1/aK
D. ) t1/2 = 3/2 K
Answer» B. t1/2 = 0.693/K
50.

The area under the serum concentration time curve of the drug represents:

A. the biological half life of the drug
B. the amount of drug in the original dosage form
C. The amount of drug absorbed
D. The amount of drug excreted in the urine
Answer» C. The amount of drug absorbed

Done Studing? Take A Test.

Great job completing your study session! Now it's time to put your knowledge to the test. Challenge yourself, see how much you've learned, and identify areas for improvement. Don’t worry, this is all part of the journey to mastery. Ready for the next step? Take a quiz to solidify what you've just studied.